BiomX Inc. (PHGE) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
22 EINSTEIN ST. NESS ZIONA, 7414003 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 14,046 | 20,116 | 16,856 | 23,537 | 31,611 | 43,007 | |||
| Cash and cash equivalent | 14,046 | 20,116 | 16,856 | 23,537 | 31,611 | 43,007 | |||
| Restricted cash and investments | 979 | 953 | 958 | 1,114 | 1,103 | 1,108 | |||
| Receivables | 690 | 1,237 | 1,171 | 395 | 395 | ||||
| Other current assets | 1,610 | 2,464 | 2,706 | 3,665 | 2,367 | 2,986 | |||
| Other undisclosed current assets | (690) | (1,237) | (1,171) | (395) | (395) | ||||
| Total current assets: | 16,635 | 23,533 | 20,520 | 28,316 | 35,081 | 47,101 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 4,959 | 5,209 | 5,457 | 9,700 | 10,423 | 11,279 | |||
| Property, plant and equipment | 4,245 | 4,701 | 5,045 | 6,581 | 6,949 | 7,438 | |||
| Intangible assets, net (including goodwill) | 801 | 801 | 15,788 | 15,788 | |||||
| Goodwill | 801 | 801 | 15,788 | 15,788 | |||||
| Restricted cash and investments | 161 | 161 | 161 | ||||||
| Other noncurrent assets | 96 | 378 | |||||||
| Other undisclosed noncurrent assets | 12,050 | 12,050 | 11,249 | 14,486 | |||||
| Total noncurrent assets: | 21,415 | 22,121 | 22,713 | 31,664 | 33,538 | 34,505 | |||
| TOTAL ASSETS: | 38,050 | 45,654 | 43,233 | 59,980 | 68,619 | 81,606 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5,029 | 5,880 | 7,137 | 7,848 | 6,258 | 9,722 | |||
| Accounts payable | 5,029 | 5,880 | 7,137 | 7,848 | 6,258 | 9,722 | |||
| Other undisclosed current liabilities | 1,233 | 1,141 | 1,130 | 1,096 | 1,047 | 985 | |||
| Total current liabilities: | 6,262 | 7,021 | 8,267 | 8,944 | 7,305 | 10,707 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 8,223 | 8,230 | 8,531 | 8,812 | 9,002 | 11,268 | |||
| Deferred revenue | 1,976 | ||||||||
| Other liabilities | 80 | 79 | 77 | 161 | 153 | 153 | |||
| Operating lease, liability | 8,143 | 8,151 | 8,454 | 8,651 | 8,849 | 9,139 | |||
| Other undisclosed noncurrent liabilities | 4,405 | 5,904 | 2,287 | 4,328 | 24,887 | 36,755 | |||
| Total noncurrent liabilities: | 12,628 | 14,134 | 10,818 | 13,140 | 33,889 | 48,023 | |||
| Total liabilities: | 18,890 | 21,155 | 19,085 | 22,084 | 41,194 | 58,730 | |||
| Temporary equity, including noncontrolling interest | 32,420 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | 19,160 | 24,499 | 24,148 | 37,896 | 27,425 | (9,544) | |||
| Preferred stock | 18,645 | 18,645 | 18,645 | 18,645 | 32,420 | ||||
| Common stock | 7 | 7 | 6 | 6 | 5 | 4 | |||
| Additional paid in capital | 194,901 | 194,203 | 186,194 | 185,429 | 170,826 | 170,749 | |||
| Accumulated deficit | (194,393) | (188,356) | (180,697) | (166,184) | (175,826) | (180,297) | |||
| Total equity: | 19,160 | 24,499 | 24,148 | 37,896 | 27,425 | (9,544) | |||
| TOTAL LIABILITIES AND EQUITY: | 38,050 | 45,654 | 43,233 | 59,980 | 68,619 | 81,606 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | (46) | 84 | 2,017 | 88 | ||||
| Other income | (70) | (6) | (46) | 84 | 2,017 | 88 | ||
| Gross profit: | (46) | 84 | 2,017 | 88 | ||||
| Operating expenses | (7,433) | (7,756) | (9,402) | (11,328) | (9,725) | (6,785) | ||
| Other undisclosed operating income (loss) | 70 | 6 | (7,237) | (84) | (2,017) | (88) | ||
| Operating loss: | (7,433) | (7,756) | (16,685) | (11,328) | (9,725) | (6,785) | ||
| Nonoperating income (expense) | (25) | (805) | 185 | 332 | 329 | (2,615) | ||
| Investment income, nonoperating | (850) | |||||||
| Other nonoperating expense | (805) | (1,765) | ||||||
| Interest and debt expense | (5) | (5) | (5) | (5) | (13) | |||
| Loss from continuing operations before equity method investments, income taxes: | (7,463) | (8,566) | (16,505) | (11,001) | (9,409) | (9,400) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,428 | 908 | 1,995 | 20,643 | 13,885 | (7,922) | ||
| Income (loss) from continuing operations before income taxes: | (6,035) | (7,658) | (14,510) | 9,642 | 4,476 | (17,322) | ||
| Income tax expense | (2) | (1) | (3) | (5) | (5) | |||
| Net income (loss) attributable to parent: | (6,037) | (7,659) | (14,513) | 9,642 | 4,471 | (17,327) | ||
| Other undisclosed net income (loss) available to common stockholders, basic | 12,074 | 15,318 | (6,428) | (14,709) | (5,426) | |||
| Net income (loss) available to common stockholders, basic: | 6,037 | 7,659 | (20,941) | (5,067) | (955) | (17,327) | ||
| Other undisclosed net income (loss) available to common stockholders, diluted | 11,037 | (4,575) | 8,352 | |||||
| Net income (loss) available to common stockholders, diluted: | 6,037 | 7,659 | (9,904) | (9,642) | 7,397 | (17,327) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (6,037) | (7,659) | (14,513) | 9,642 | 4,471 | (17,327) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (6,037) | (7,659) | (14,513) | 9,642 | 4,471 | (17,327) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.